These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17276431)

  • 1. Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin.
    Guido M; Romualdi D; De Marinis L; Porcelli T; Giuliani M; Costantini B; Lanzone A
    Fertil Steril; 2007 Jul; 88(1):125-30. PubMed ID: 17276431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
    Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metformin on the growth hormone response to growth hormone-releasing hormone in obese women with polycystic ovary syndrome.
    Guido M; Romualdi D; Giuliani M; Suriano R; Tienforti D; Costantini B; Lanzone A
    Fertil Steril; 2005 Nov; 84(5):1470-6. PubMed ID: 16275246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome.
    Moran C; Renteria JL; Moran S; Herrera J; Gonzalez S; Bermudez JA
    Fertil Steril; 2008 Dec; 90(6):2310-7. PubMed ID: 18163993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired growth hormone secretion after glucose loading in non-obese women with polycystic ovary syndrome, possibly related to androgen but not insulin and free fatty acids.
    Takeuchi T; Tsutsumi O; Taketani Y
    Gynecol Endocrinol; 2007; 23(8):468-73. PubMed ID: 17852425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome.
    Ludwig AK; Goharian LG; Dietze T; Tauchert S; Rudolf S; Diedrich K; Schweiger U; Oltmanns KM
    Fertil Steril; 2009 Jul; 92(1):271-6. PubMed ID: 18692843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
    Alvarez-Castro P; Isidro ML; Garcia-Buela J; Leal-Cerro A; Broglio F; Tassone F; Ghigo E; Dieguez C; Casanueva FF; Cordido F
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone and ghrelin secretion in severely obese women before and after bariatric surgery.
    Valera Mora ME; Manco M; Capristo E; Guidone C; Iaconelli A; Gniuli D; Rosa G; Calvani M; Mingrone G
    Obesity (Silver Spring); 2007 Aug; 15(8):2012-8. PubMed ID: 17712119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome.
    Bik W; Baranowska-Bik A; Wolinska-Witort E; Chmielowska M; Martynska L; Baranowska B
    Gynecol Endocrinol; 2007 Jun; 23(6):325-31. PubMed ID: 17616856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome.
    Waśko R; Komarowska H; Warenik-Szymankiewicz A; Sowiński J
    Horm Metab Res; 2004 Mar; 36(3):170-3. PubMed ID: 15057670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome.
    Romualdi D; Giuliani M; Draisci G; Costantini B; Cristello F; Lanzone A; Guido M
    Fertil Steril; 2007 Jul; 88(1):131-8. PubMed ID: 17336978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese children.
    Baldelli R; Bellone S; Castellino N; Petri A; Rapa A; Vivenza D; Bellone J; Broglio F; Ghigo E; Bona G
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):255-9. PubMed ID: 16487433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
    Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.
    Maciel GA; Soares Júnior JM; Alves da Motta EL; Abi Haidar M; de Lima GR; Baracat EC
    Fertil Steril; 2004 Feb; 81(2):355-60. PubMed ID: 14967373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glucose and lipid metabolism in patients with polycystic ovary syndrome].
    Ge XL; Lou SZ; Shen HM
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):527-30, 573. PubMed ID: 7835128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.